GP Pharm to Exhibit at CPhI 2011
For the eighth consecutive year GP Pharm will be present at CPhI, the world's most...
GP Pharm: Injectable Products for the Urology, Oncology, CNS and CVS Fields
GP Pharm, the pharmaceutical company of the Lipotec Group, specialises in the research, development, production and marketing of injectable products within the urology, oncology, central nervous system and cardiovascular fields, some of them based in proprietary drug delivery systems.
Download this free whitepaper to find out more.
More About This Company
PHOENIX Study Proposes Integration Measures Between the Financial World and Biotechnological Companies
CataloniaBIO has launched the PHOENIX Study to get the financial world's vision about the sector...
GP Pharm Expands its Pharmaceutical Line Against Advanced Colorectal Cancer with Oxaliplatin and Irinotecan 300mg and 500mg
GP Pharm has started the commercialisation of Oxaliplatin and Irinotecan 300mg and 500mg, drugs to...
GP Pharm Obtains Approval for GCC Countries
Last January, GCC-DR (Gulf Central Committee for Drug Registration) granted a Registration Certificate of Manufacturing...